Clinical, histologic and serologic evaluation of patients with acute non-A-E hepatitis in north-eastern Brazil: Is it an infectious disease?

International Journal of Infectious Diseases

Volumn 7, Issue 3, 2003, Pages 222-230

  Paraná, Raymundo ^a,b,e   Codes, Liana ^a,b   Andrade, Zilton ^c   De Freitas, Luiz A R ^c   Santos Jesus, Rogério ^a,b   Reis, Mitermayer ^c   Cotrim, Helma ^a,b   Cunha, Simone ^a,b   Trepo, Christian ^d  

^a Hospital Portugues (Salvador Bahia)   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d INSERM   (France)

^e NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; FERRITIN;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAZIL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONVALESCENCE; DISEASE COURSE; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS G VIRUS; HEPATITIS NON A TO E; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MALE; SERODIAGNOSIS; SYMPTOM; TORQUE TENO VIRUS;

EID: 0142215419     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(03)90056-7     Document Type: Article

References (37)

1. Buti M, Jardi R, Rodriguez-Frias F. Non-A, non-B, non-C, non-E acute hepatitis: does it really exist? In: Nishioka K, Suziki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease. Tokyo: Springer-Varlag, 1994:77-79.
2. Bruguera M, Sanchez-Tapias JM. What are cryptogenic hepatic diseases? Med Clin (Barc) 2000; 114(1):31-36.
3. Charlton MR, Kondo M, Roberts SK, et al. Liver transplantation for cryptogenic cirrhosis. Liver Transplant Surg 1997; 3(4):359-364.
4. Alter MJ, Gallagher M, Morris TT, et al. Acute non A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 336:741-746.
5. Kato T, Mizokami M, Orito E, et al. High prevalence of TT virus infection in Japanese patients with liver diseases and in blood donors. J Hepatol 1999; 31:221-227.
6. Brojer E, Grabarczyk P, Kryczka W, et al. Analysis of hepatitis G virus infection markers in blood donors and patients with hepatitis. J Viral Hepatol 1999; 6:471-475.
7. Li JS, Tong SP, Vitvitski L, et al. Single-step nested polymerase chain reaction for detection of different genotypes of hepatitis C virus. J Med Virol 1995; 45:151-155.
8. Jarvis LM, Davidson F, Hanley JP, et al. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348:1352-1355.
9. Biagini P, Gallian P, Attoui H, et al. Determination and phylogenetic analysis of partial sequences from TT virus isolate. J Gen Virol 1999; 80:419-424.
10. Greeve M, Ferrell L, Kim M, et al. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Hepatology 1993; 17(4):593-598.
11. Alter HJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus. Semin Liver Dis 1995; 15:110-120.
12. Tassopoulos NC, Kuhns M, Hadziyannis S. Clinical and laboratory features of acute community acquired non-A, non-B, non-C hepatitis. In: Nishioka K, Suzuki H, Machiro S, Oda T, ed. Viral hepatitis and liver diseases. Tokyo: Springer-Verlag, 1994:80-84.
13. Paraná Vitvitski L, Andrade Z, et al. Acute sporadic non-A, non-B hepatitis in northeastern Brazil: etiology and natural history. Hepatology 1999; 30(1):289-293.
14. Frider B, Sookoian S, Castano G, et al. Detection of hepatitis G virus RNA in patients with acute non A-E hepatitis. J Viral Hepatol 1998; 5(3):161-164.
15. Wright TL, Hsu H, Donegan E. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991; 115:111-112.
16. Mason AL, Perrillo RP. The A to E and new hepatotropic viruses. Liver Transplant Surg 1996; 2:208-215.
17. Fagan EA. Acute liver failure of unknown pathogenesis: the hidden agenda. Hepatology 1994; 19:1307-1312.
18. Phillips MJ, Blendos LM, Purcell S. Syncitial giant-cell hepatitis. N Engl J Med 1991; 324:455-460.
19. Meng G, Lan Y, Nakagawa M, et al. High prevalence of hantavirus infection in a group of Chinese patients with acute hepatitis of unknown aetiology. J Viral Hepatol 1997; 4(4):231-234.
20. Arankalle VA, Chadha MS, Tsarev SA, et al. Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. Proc Natl Acad Sci USA 1994; 91:3428-3432.
21. Mushahwar IK, Zuckerman JN. Clinical implications of GB virus C. J Med Virol 1998; 56:1-3.
22. Thiers V, Pol S, Pertiso T, et al. Hepatitis G virus infection in hepatitis C virus positive patients co-infected or not with hepatitis B and/or human immunodeficiency virus. J Viral Hepatol 1998; 5:123-130.
23. Jiang RL, Lu Q, Luo KX, et al. A prospective study of transfusion-transmitted virus transmission by blood transfusion. J Viral Hepatol 1999; 6:49-51.
24. Tagger A, Donato F, Ribero ML, et al. A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. Hepatology 1999; 30(1):294-299.
25. Nishizawa T, Okamoto H, Konishi K, et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusional hepatitis of unknown etiology. Biochem Biophys Res Commun 1997; 241:92-97.
26. Okamoto H, Nishisawa T, Kato N, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusional hepatitis of unknown etiology. Hepatol Res 1998; 10:11-16.
27. Takahashi K, Ohta Y, Yoshida N, et al. Very high prevalence of TTV infection in general population of Japan revealed by a new set of PCR primers. Hepatology 1998; 12:233-239.
28. Naoumov NV, Ptrova EP, Thomas MG, et al. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 1998; 352:195-197.
29. Kato T, Mizokami M, Orito E, et al. High prevalence of TT virus infection in Japanese patients with liver diseases and in blood donors. J Hepatol 1999; 31:221-227.
30. Uemura T, Donahue P, Sottini A, et al. The incidence of SEN virus infection in transfusion-associated hepatitis. Antiviral Therapy 2000; 5 (suppl 1): 11.
31. Alter H. Beyond the C: new viruses and their relationship to hepatitis. In: Hoofnagle J, Schiff E, eds. Update on viral hepatitis/AASLD Postgraduate course, 2000:68-75.
32. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 1993; 105:1522-1528.
33. Riggio O, Montagnese F, Fiore P, et al. Iron overload in patients with chronic viral hepatitis: how commom is it? Am J Gastroenterol 1997; 92(8):1298-1301.
34. Pessoa MG, Terrault NA, Ferrell LD, et al. Hepatitis after liver transplantation: the role of known and unknown viruses. Liver Transplant Surg 1988; 4(6):461-468.
35. Ku NO, Wright TL, Terrault NA, et al. Mutation of human keratin 18 in association with cryptogenic cirrhosis. J Clin Invest 1997; 99(1):19-23.
36. Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341(1):22-26.
37. Watanabe A, Aiba N, Harada R, et al. Etiology and prognosis of cryptogenic liver cirrhosis: possible contribution of hepatitis B virus. J Med 1997; 28(1-2):31-44.